
Sign up to save your podcasts
Or


Episode 2816 - In this wide-ranging and spiritually charged episode, Ted and Austin Broer connect Ozempic psychiatric dangers, magnesium’s biochemical centrality, nicotine pouch targeting of teenagers, AI data center off-grid capabilities, alien disclosure spiritual context, and foundational collagen science into a broadcast that challenges listeners to protect their mental health, their children, and their spiritual discernment simultaneously. The episode opens with Austin delivering one of the most important pharmaceutical warning segments the show has produced in recent memory, documenting Ozempic’s 45% elevated suicidal ideation risk alongside its connections to pancreatic problems, thyroid cancer, vision loss, severe gastrointestinal side effects, and the facial and body fat redistribution that has driven demand for cosmetic procedures among long-term users. Both hosts make the case that the semaglutide class of drugs is producing a psychiatric and metabolic harm profile that vastly outweighs the weight loss benefit being sold to millions of trusting patients.
By healthmasters.com4.6
728728 ratings
Episode 2816 - In this wide-ranging and spiritually charged episode, Ted and Austin Broer connect Ozempic psychiatric dangers, magnesium’s biochemical centrality, nicotine pouch targeting of teenagers, AI data center off-grid capabilities, alien disclosure spiritual context, and foundational collagen science into a broadcast that challenges listeners to protect their mental health, their children, and their spiritual discernment simultaneously. The episode opens with Austin delivering one of the most important pharmaceutical warning segments the show has produced in recent memory, documenting Ozempic’s 45% elevated suicidal ideation risk alongside its connections to pancreatic problems, thyroid cancer, vision loss, severe gastrointestinal side effects, and the facial and body fat redistribution that has driven demand for cosmetic procedures among long-term users. Both hosts make the case that the semaglutide class of drugs is producing a psychiatric and metabolic harm profile that vastly outweighs the weight loss benefit being sold to millions of trusting patients.

1,621 Listeners

1,038 Listeners

1,093 Listeners

672 Listeners

1,834 Listeners

1,374 Listeners

698 Listeners

237 Listeners

550 Listeners

497 Listeners

387 Listeners

413 Listeners

483 Listeners

372 Listeners

742 Listeners